Literature DB >> 25705271

High Incidence of Macrolide and Tetracycline Resistance among Streptococcus Agalactiae Strains Isolated from Clinical Samples in Tehran, Iran.

Mohammad Emaneini1, Akbar Mirsalehian1, Reza Beigvierdi1, Abbas Ali Imani Fooladi2, Fatemeh Asadi1, Fereshteh Jabalameli1, Morovat Taherikalani3.   

Abstract

BACKGROUND: Streptococcus agalactiae or Group B Streptococci (GBS) is an important bacterial pathogen that causes a wide range of infections including neonatal sepsis, meningitis, pneumonia and soft tissue or urinary tract infections.
MATERIAL AND METHODS: One hundred and fifteen isolates of Streptococcus agalactiae collected from urine specimens of patients attending a hospital in Tehran. All isolates were screened for their capsular types and genes encoding resistance to the macrolide and tetracycline antibiotics by PCR and multiplex PCR-based methods.
RESULTS: Most of isolates belonged to capsular types III (49%), V (19%), II (16%), and Ib (6%). Twelve isolates (10%) were nontypable. All isolates were susceptible to penicillin and Quinupristin-dalfopristin, but were resistant to clindamycin (35%), chloramphenicol (45%), erythromycin (35%), linezolid (1%) and tetracycline (96%). The most prevalent antimicrobial resistance gene was tetM found in 93% of the isolates followed by ermTR, ermB, and tetK, found in 23%, 16%, and 16% of isolates, respectively. The genes, tetL, tetO, ermA, ermC and mefA were not detected in any of the S. agalactiae isolates. Of the 110 tetracycline resistant S. agalactiae, 89 isolates harbored the tetM gene alone and eighteen isolates carried the tetM gene with the tetK gene. All erythromycin-resistant isolates exhibited cMLSB resistance phenotype, 22 isolates harbored the ermTR gene alone and five isolates carried the ermTR gene with the ermB gene. The rate of coexistence of genes encoding the erythromycin and tetracycline resistance determinants was 34%.
CONCLUSION: The present study demonstrated that S. agalactiae isolates obtained from urine samples showed a high rate of resistance to tetracycline, chloramphenicol and macrolide antibiotics and were commonly associated with the resistance genes temM, ermTR or ermB.

Entities:  

Keywords:  Streptococcus agalactiae; capsular type; ermTR; tetM

Year:  2014        PMID: 25705271      PMCID: PMC4296758     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  27 in total

1.  Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates.

Authors:  A Amin; Y M Abdulrazzaq; S Uduman
Journal:  J Infect       Date:  2002-07       Impact factor: 6.072

Review 2.  Genetic elements responsible for erythromycin resistance in streptococci.

Authors:  Pietro E Varaldo; Maria Pia Montanari; Eleonora Giovanetti
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

3.  Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family.

Authors:  C Florindo; S Viegas; A Paulino; E Rodrigues; J P Gomes; M J Borrego
Journal:  Clin Microbiol Infect       Date:  2010-09       Impact factor: 8.067

4.  Serotypes and antibiotic resistance in Group B streptococcus isolated from patients at the Maternity Hospital, Kuwait.

Authors:  Samar S Boswihi; Edet E Udo; Noura Al-Sweih
Journal:  J Med Microbiol       Date:  2011-09-08       Impact factor: 2.472

5.  Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae.

Authors:  Esther Culebras; Iciar Rodriguez-Avial; Carmen Betriu; Montserrat Redondo; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

6.  Type IV neonatal early-onset group B streptococcal disease in a United States hospital.

Authors:  Karen M Puopolo; Lawrence C Madoff
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

7.  Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women.

Authors:  Sandra Pinheiro; Hajer Radhouani; Céline Coelho; Alexandre Gonçalves; Eulália Carvalho; José António Carvalho; Fernanda Ruiz-Larrea; Carmen Torres; Gilberto Igrejas; Patrícia Poeta
Journal:  Microb Drug Resist       Date:  2009-06       Impact factor: 3.431

8.  The prevalence of erythromycin resistance in group B streptococcal isolates at a University Hospital in Taiwan.

Authors:  Rajendra Prasad Janapatla; Yueh-Ren Ho; Jing-Jou Yan; Hsiu-Mei Wu; Jiunn-Jong Wu
Journal:  Microb Drug Resist       Date:  2008-12       Impact factor: 3.431

Review 9.  Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Authors:  A Schuchat
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

10.  Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).

Authors:  Virginia Rubio-López; Sylvia Valdezate; David Alvarez; Pilar Villalón; María José Medina; Celia Salcedo; Juan-Antonio Sáez-Nieto
Journal:  BMC Microbiol       Date:  2012-09-21       Impact factor: 3.605

View more
  8 in total

1.  ANTIMICROBIAL SUSCEPTIBILITY OF Streptococcus agalactiae ISOLATED FROM PREGNANT WOMEN.

Authors:  Simone Cristina Castanho Sabaini de Melo; Nathally Claudiane de Souza Santos; Marcia de Oliveira; Regiane Bertin de Lima Scodro; Rosilene Fressatti Cardoso; Rúbia Andreia Falleiros Pádua; Flavia Teixeira Ribeiro Silva; Aline Balandis Costa; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

2.  Survey of strain distribution and antibiotic resistance pattern of group B streptococci (Streptococcus agalactiae) isolated from clinical specimens.

Authors:  Seyed Masoud Mousavi; Mona Nasaj; Seyed Mostafa Hosseini; Mohammad Reza Arabestani
Journal:  GMS Hyg Infect Control       Date:  2016-09-12

3.  Clonal Distribution of Clindamycin-Resistant Erythromycin-Susceptible (CRES) Streptococcus agalactiae in Korea Based on Whole Genome Sequences.

Authors:  Takashi Takahashi; Takahiro Maeda; Seungjun Lee; Dong-Hyun Lee; Sunjoo Kim
Journal:  Ann Lab Med       Date:  2020-09       Impact factor: 3.464

4.  Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples.

Authors:  Raymond Mudzana; Rooyen T Mavenyengwa; Muchaneta Gudza-Mugabe
Journal:  BMC Infect Dis       Date:  2021-01-28       Impact factor: 3.090

5.  Molecular Characterization of Hospital- and Community-Acquired Streptococcus agalactiae Isolates among Nonpregnant Adults in Isfahan, Iran.

Authors:  Tahereh Motallebirad; Hossein Fazeli; Saba Jalalifar; Darioush Shokri; Sharareh Moghim; Bahram Nasr Esfahani
Journal:  Adv Biomed Res       Date:  2020-09-30

6.  Macrolide-resistance, capsular genotyping and associated factors of group B Streptococci colonized pregnant women in Isfahan, Iran.

Authors:  Soodabeh Rostami; Leila Moeineddini; Fereshteh Ghandehari; Marzieh Rahim Khorasani; Parisa Shoaei; Nasim Ebrahimi
Journal:  Iran J Microbiol       Date:  2021-04

7.  Antimicrobial resistance in colonizing group B Streptococcus among pregnant women from a hospital in Vietnam.

Authors:  Vu Van Du; Pham Thai Dung; Nguyen Linh Toan; Can Van Mao; Nguyen Thanh Bac; Hoang Van Tong; Ho Anh Son; Nghiem Duc Thuan; Nguyen Thanh Viet
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

8.  New Insights on Streptococcus dysgalactiae subsp. dysgalactiae Isolates.

Authors:  Cinthia Alves-Barroco; João Caço; Catarina Roma-Rodrigues; Alexandra R Fernandes; Ricardo Bexiga; Manuela Oliveira; Lélia Chambel; Rogério Tenreiro; Rosario Mato; Ilda Santos-Sanches
Journal:  Front Microbiol       Date:  2021-07-15       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.